NEW GONOW RV (00805.HK): Discloses High Shareholding Concentration at HKEX Request
NewTimeSpace News: On 26 October 2026, New Gonow Recreational Vehicles Inc. (stock code: 805) published an announcement at the request of the Stock Exchange of Hong Kong concerning the concentration of its shareholding in a small number of shareholders as at 13 October 2026, setting out the announcement issued by the Securities and Futures Commission (SFC) on 26 October 2026.
According to the announcement, the SFC recently conducted an inquiry into the Company's shareholding distribution, which showed that as at 13 October 2026, 22 shareholders and their related persons held a total of 400,219,592 shares, representing 41.69% of the issued shares. Together with the 467,470,122 shares (48.69%) held by Mr Miao Xuezhong, the chairman and chief executive officer, these holdings represented 90.38% of the issued shares; only 92,310,286 shares (9.62%) were held by other shareholders. Total issued shares are 960,000,000.
Citing the SFC announcement, the Company noted that its share price rose 878.6% from HK$1.40 on 30 April 2026 to HK$13.70 on 13 October 2026, and closed at HK$14.00 on 23 October 2026, 900% above the 30 April closing price.
The Company said the information is extracted from the SFC announcement and, apart from the number of shares held by Mr Miao through Snowy.M Holdings Limited (based on the latest disclosure of interests under Part XV of the Securities and Futures Ordinance) and the share price data, it has not independently verified the information. It will conduct further investigation into the shareholding matters and announce updates as soon as practicable after completing the investigation.
The Company confirmed that, as at 13 October 2026 and the date of the announcement, at least 25% of its issued shares were held by the public, in compliance with the public float requirement. It cautioned that, given the high concentration of shareholding, the share price may fluctuate significantly even on small trading volumes and its securities may not have a genuine market.
- ZHAOKE OPHTH-B (06622.HK): Guangzhou Nansha Site Obtains TGA GMP Certification
- INSILICO (03696.HK): First-in-Human ISM6331 Data Show 40% ORR in 130mg Mesothelioma Cohort
- HUTCHMED (00013.HK): Expert Briefing on Savolitinib Set for 5 November
- SBP GROUP (01177.HK): Two Hepatitis B Drugs Granted CDE Breakthrough Therapy Status
- JIANGSU EXPRESSWAY (00177.HK): Acquires 100% of Sunan Expressway for RMB7.345bn